187 related articles for article (PubMed ID: 25665954)
1. Beneficial antioxidant properties of betaine against oxidative stress mediated by levodopa/benserazide in the brain of rats.
Alirezaei M; Khoshdel Z; Dezfoulian O; Rashidipour M; Taghadosi V
J Physiol Sci; 2015 May; 65(3):243-52. PubMed ID: 25665954
[TBL] [Abstract][Full Text] [Related]
2. Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats.
Alirezaei M
Iran J Basic Med Sci; 2015 Oct; 18(10):950-7. PubMed ID: 26730328
[TBL] [Abstract][Full Text] [Related]
3. Betaine prevents ethanol-induced oxidative stress and reduces total homocysteine in the rat cerebellum.
Alirezaei M; Jelodar G; Niknam P; Ghayemi Z; Nazifi S
J Physiol Biochem; 2011 Dec; 67(4):605-12. PubMed ID: 21698419
[TBL] [Abstract][Full Text] [Related]
4. Effects of piclozotan (SUN N4057), a partial serotonin 1A receptor agonist, on motor complications induced by repeated administration of levodopa in parkinsonian rats.
Tani Y; Ogata A; Koyama M; Inoue T
Eur J Pharmacol; 2010 Dec; 649(1-3):218-23. PubMed ID: 20858480
[TBL] [Abstract][Full Text] [Related]
5. Effects of carnosine plus vitamin E and betaine treatments on oxidative stress in some tissues of aged rats.
Çoban J; Bingül I; Yesil-Mizrak K; Dogru-Abbasoglu S; Oztezcan S; Uysal M
Curr Aging Sci; 2013 Jul; 6(2):199-205. PubMed ID: 23701646
[TBL] [Abstract][Full Text] [Related]
6. The effect of levodopa benserazide hydrochloride on homocysteinemia levels in patients with Parkinson's disease and treatment of hyperhomocysteinemia.
Guo G; Xu S; Cao LD; Wu QY
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2409-12. PubMed ID: 27338068
[TBL] [Abstract][Full Text] [Related]
7. Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats.
Yang X; Chen Y; Hong X; Wu N; Song L; Yuan W; Liu Z
Drug Des Devel Ther; 2012; 6():341-7. PubMed ID: 23185117
[TBL] [Abstract][Full Text] [Related]
8. Betaine supplementation protects against renal injury induced by cadmium intoxication in rats: role of oxidative stress and caspase-3.
Hagar H; Al Malki W
Environ Toxicol Pharmacol; 2014 Mar; 37(2):803-11. PubMed ID: 24632105
[TBL] [Abstract][Full Text] [Related]
9. Oral Supplements of
Mohammed NA; Abdou HM; Tass MA; Alfwuaires M; Abdel-Moneim AM; Essawy AE
Curr Pharm Biotechnol; 2020; 21(12):1259-1268. PubMed ID: 32196446
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
Pan X; Chen C; Huang J; Wei H; Fan Q
Neurosci Lett; 2015 Jul; 600():220-5. PubMed ID: 26101828
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and paraoxonase activity in experimental selenosis: effects of betaine administration.
Harisa GI
Biol Trace Elem Res; 2013 May; 152(2):258-66. PubMed ID: 23385851
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of major histocompatibility complex class II-positive cells in the postischemic brain--influence of levodopa treatment.
Kuric E; Ruscher K
J Neuroinflammation; 2014 Aug; 11():145. PubMed ID: 25178113
[TBL] [Abstract][Full Text] [Related]
13. Attenuating effects of caffeic acid phenethyl ester and betaine on abamectin-induced hepatotoxicity and nephrotoxicity.
Abdel-Daim MM; Abdellatief SA
Environ Sci Pollut Res Int; 2018 Jun; 25(16):15909-15917. PubMed ID: 29589235
[TBL] [Abstract][Full Text] [Related]
14. [Effects of traditional Chinese herbal medicine on the neurobehavioral manifestations and the activity of dopamine D2 receptor in corpora striatum of rats with levodopa-induced dyskinesias].
Yuan CX; Ye Q; Wang J; Zhang Y; Yuan CG
Zhong Xi Yi Jie He Xue Bao; 2008 Oct; 6(10):1024-8. PubMed ID: 18847536
[TBL] [Abstract][Full Text] [Related]
15. Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.
Xie CL; Wang WW; Zhang SF; Yuan ML; Che JY; Gan J; Song L; Yuan WE; Liu ZG
Sci Rep; 2014 Dec; 4():7506. PubMed ID: 25511986
[TBL] [Abstract][Full Text] [Related]
16. Studies on the protective effects of betaine against oxidative damage during experimentally induced restraint stress in Wistar albino rats.
Ganesan B; Anandan R; Lakshmanan PT
Cell Stress Chaperones; 2011 Nov; 16(6):641-52. PubMed ID: 21717086
[TBL] [Abstract][Full Text] [Related]
17. Controlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats.
Yang X; Zheng R; Cai Y; Liao M; Yuan W; Liu Z
Int J Nanomedicine; 2012; 7():2077-86. PubMed ID: 22619544
[TBL] [Abstract][Full Text] [Related]
18. New L-dopa codrugs as potential antiparkinson agents.
Sozio P; Iannitelli A; Cerasa LS; Cacciatore I; Cornacchia C; Giorgioni G; Ricciutelli M; Nasuti C; Cantalamessa F; Di Stefano A
Arch Pharm (Weinheim); 2008 Jul; 341(7):412-7. PubMed ID: 18581391
[TBL] [Abstract][Full Text] [Related]
19. Effects of 17β-estradiol and antioxidant administration on oxidative stress and insulin resistance in ovariectomized rats.
Abbas AM; Elsamanoudy AZ
Can J Physiol Pharmacol; 2011 Jul; 89(7):497-504. PubMed ID: 21812527
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease.
Putterman DB; Munhall AC; Kozell LB; Belknap JK; Johnson SW
J Pharmacol Exp Ther; 2007 Oct; 323(1):277-84. PubMed ID: 17660384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
